CHITOGENX INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.065 CAD | 0.00% |
|
0.00% | 0.00% |
| Feb. 28 | Chitogenxinc. Announces Resignation of Philippe Deschamps from the Board of Directors | CI |
| Feb. 28 | Chitogenx Inc. Announces CEO Changes | CI |
Valuation
| Fiscal Period: January | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 10.31 | 4.95 | 6.312 | 21.43 | 12.06 | 13.27 |
| Enterprise Value (EV) 1 | 10.97 | 5.583 | 8.675 | 23.67 | 17.46 | 19.48 |
| P/E ratio | -4.29 x | -2.06 x | -2.54 x | -4.73 x | -2.45 x | -2.01 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -6.78 x | -2.52 x | -4.41 x | -9.85 x | -5.48 x | -4.19 x |
| EV / FCF | -7.65 x | -6.2 x | -7.88 x | -14.2 x | -9.18 x | -38.5 x |
| FCF Yield | -13.1% | -16.1% | -12.7% | -7.05% | -10.9% | -2.6% |
| Price to Book | 70.4 x | -8.4 x | -2.63 x | -11.9 x | -1.7 x | -1.35 x |
| Nbr of stocks (in thousands) | 20,611 | 24,752 | 24,752 | 34,568 | 34,956 | 51,039 |
| Reference price 2 | 0.5000 | 0.2000 | 0.2550 | 0.6200 | 0.3450 | 0.2600 |
| Announcement Date | 5/18/18 | 5/30/19 | 5/29/20 | 5/31/21 | 5/19/22 | 5/31/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: January | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | - | - | - |
| EBITDA 1 | -1.619 | -2.216 | -1.965 | -2.402 | -3.188 | -4.65 |
| EBIT 1 | -1.643 | -2.305 | -2.063 | -2.476 | -3.257 | -4.709 |
| Operating Margin | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -2.022 | -2.399 | -2.488 | -3.772 | -4.921 | -6.23 |
| Net income 1 | -2.022 | -2.399 | -2.488 | -3.772 | -4.921 | -6.23 |
| Net margin | - | - | - | - | - | - |
| EPS 2 | -0.1167 | -0.0969 | -0.1005 | -0.1312 | -0.1410 | -0.1291 |
| Free Cash Flow 1 | -1.434 | -0.9004 | -1.1 | -1.668 | -1.901 | -0.5059 |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/18/18 | 5/30/19 | 5/29/20 | 5/31/21 | 5/19/22 | 5/31/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: January | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | -1.657 | -0.791 | - | -1.439 | -1.484 | -1.09 | -1.058 | -0.584 |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -1.923 | -0.851 | - | -1.363 | -1.857 | -2.16 | -0.097 | -0.409 |
| Net income 1 | -0.904 | -1.923 | -0.851 | -0.85 | -1.363 | -1.857 | -2.16 | -0.097 | -0.409 |
| Net margin | - | - | - | - | - | - | - | - | - |
| EPS 2 | -0.0300 | -0.0600 | -0.0200 | -0.0200 | -0.0300 | -0.0400 | -0.0400 | - | -0.0100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 9/30/21 | 12/21/21 | 5/19/22 | 6/23/22 | 9/28/22 | 12/28/22 | 5/31/23 | 6/29/23 | 9/29/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: January | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.67 | 0.63 | 2.36 | 2.24 | 5.4 | 6.21 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.4135 x | -0.2852 x | -1.203 x | -0.9309 x | -1.693 x | -1.335 x |
| Free Cash Flow 1 | -1.43 | -0.9 | -1.1 | -1.67 | -1.9 | -0.51 |
| ROE (net income / shareholders' equity) | 361% | 1,084% | 167% | 180% | 111% | 73.5% |
| ROA (Net income/ Total Assets) | -91% | -92.5% | -89.2% | -67.8% | -92.5% | -316% |
| Assets 1 | 2.223 | 2.593 | 2.789 | 5.562 | 5.318 | 1.97 |
| Book Value Per Share 2 | 0.0100 | -0.0200 | -0.1000 | -0.0500 | -0.2000 | -0.1900 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.0100 | 0.0700 | 0.0100 | 0 |
| Capex 1 | 0.16 | 0.08 | - | 0 | 0.03 | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 5/18/18 | 5/30/19 | 5/29/20 | 5/31/21 | 5/19/22 | 5/31/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 3.95M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- CHGX Stock
- Financials ChitogenX Inc.
